Archer Investment Corporation’s Jazz Pharmaceuticals JAZZ Stock Holding History

Archer Investment Corporation’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45K	Hold	6	–	–	﹤0.01%	1077
2026 Q1	$1.13K	Hold	6	–	–	﹤0.01%	1105
2025 Q4	$1.02K	Hold	6	–	–	﹤0.01%	1055
2025 Q3	$791	Hold	6	–	–	﹤0.01%	1079
2025 Q2	$637	Hold	6	–	–	﹤0.01%	1063
2025 Q1	$745	Hold	6	–	–	﹤0.01%	1022
2024 Q4	$739	Hold	6	–	–	﹤0.01%	1022
2024 Q3	$668	Hold	6	–	–	﹤0.01%	999
2024 Q2	$640	Hold	6	–	–	﹤0.01%	992
2024 Q1	$723	Sell	6 -500	-99%	-$61.2K	﹤0.01%	972
2023 Q4	$62.2K	Hold	506	–	–	0.02%	369
2023 Q3	$65.5K	Hold	506	–	–	0.02%	341
2023 Q2	$62.7K	Hold	506	–	–	0.02%	352
2023 Q1	$69.8K	Buy	506 +500	+8,333%	+$74K	0.03%	330
2022 Q4	$956	Hold	6	–	–	﹤0.01%	751
2022 Q3	$800	Hold	6	–	–	﹤0.01%	742
2022 Q2	$936	Hold	6	–	–	﹤0.01%	742
2022 Q1	$961	Hold	6	–	–	﹤0.01%	746
2021 Q4	$764	Hold	6	–	–	﹤0.01%	747
2021 Q3	$781	Buy	+6	New	+$907	﹤0.01%	686

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Archer Investment Corporation's JAZZ Position: Q2 2026 in Review

Archer Investment Corporation held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 6 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Archer Investment Corporation first reported a position in JAZZ in Q3 2021 and has held it in 20 quarters since. The position peaked at $69.8K in Q1 2023. 420 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Archer Investment Corporation held 6 shares of Jazz Pharmaceuticals worth $1.45K as of Q2 2026.
Archer Investment Corporation left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #1077 holding.
Archer Investment Corporation first reported a position in Jazz Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
Archer Investment Corporation's Jazz Pharmaceuticals position peaked at $69.8K in Q1 2023.
420 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.